AC Immune SA
NASDAQ:ACIU
AC Immune SA
NASDAQ:ACIU
Price:
2.35 USD
2.62%
Market Closed
Updated:
Apr 27, 2024
AC Immune SA
Cash from Investing Activities
|
AC Immune SA
Cash from Investing Activities Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AC Immune SA
NASDAQ:ACIU
|
Cash from Investing Activities
CHf65.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Investing Activities
-$3.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Investing Activities
$374.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Investing Activities
-CHf1m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
30%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Cash from Investing Activities
CHf743.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash from Investing Activities
-CHf326k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's Cash from Investing Activities?
Cash from Investing Activities
65.6m
CHF
65.6m
CHF
Based on the financial report for Dec 31, 2023, AC Immune SA's Cash from Investing Activities amounts to 65.6m CHF.
What is AC Immune SA's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
32%
32%
Over the last year, the Cash from Investing Activities growth was 176%. The average annual Cash from Investing Activities growth rates for AC Immune SA have been 32% over the past three years .
You don't have any saved screeners yet
